BUFFALO GROVE, IL - Private equity firm Golden Gate Capital announced that investment funds managed by the company have successfully completed the acquisition of ANGUS Chemical Co. (ANGUS), Buffalo Grove, IL, from The Dow Chemical Co.
ANGUS will continue to be led by its current senior management team, including President and CEO Mark A. Henning. Additionally, ANGUS will continue to honor all customer, licensing and supplier contracts and related agreements.
“We strongly support ANGUS management and believe their strategic vision for the company will drive long-term success,” said Rajeev Amara, Managing Director at Golden Gate Capital. “Looking ahead, we are focused on working with the ANGUS team to invest in targeted growth areas through their Customer Application Centers as well as in their people, capacity and next-generation R&D pipeline.”
As previously announced, the $1.215 billion transaction includes the ANGUS business headquarters and R&D facility in Buffalo Grove, IL; manufacturing facilities located in Sterlington, LA, and Ibbenbueren, Germany; a life-science additive facility in Niagara Falls, NY; as well as the associated business, inventory, customer contracts, process technology, business know-how and certain intellectual property.